Chicago Partners Investment Group LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1563525
CHICAGO, IL
Position in NBIX
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$973,426
+$213,360 QoQ
Shares Held
7,389
+37.9% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
4 quarters on record
Voting authority
Sole 9%
Shared 0%
None 91%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Chicago Partners Investment Group LLC holds $3,214,780 across 10 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (30.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
7,389 | $973,426 | |
| 2 | ZTS |
Zoetis Inc.
|
6,340 | $749,451 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,159 | $687,263 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
13,887 | $332,315 | |
| 5 | VTRS |
Viatris Inc
|
15,081 | $203,744 | |
| 6 | EOLS |
Evolus, Inc.
|
19,291 | $79,286 | |
| 7 | XERS |
Xeris Biopharma Holdings, Inc.
|
13,493 | $78,259 | |
| 8 | IRWD |
Ironwood Pharmaceuticals Inc
|
18,483 | $64,875 |
All Filings in NBIX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $973,426 | 7,389 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $760,066 | 5,359 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $500,595 | 3,566 | Shares | Sole | 2025-10-30 | |
| 2024-12-31 | $250,614 | 1,836 | Shares | Sole | 2025-01-24 | |
| No filing history on record for this holder in this stock. | ||||||